Supercomputer Helps Supersize Cancer Research at Hormel
The process of conducting cancer research is getting faster for a group of University of Minnesota scientists.
Representatives from the Hormel Institute announced they’ve purchased an IBM (NYSE: IBM) Blue Gene supercomputer capable of processing 5-6 trillion operations a second – a speed that’ll allow Hormel to triple the number of research projects it undertakes. As one Hormel official explained,
“You use other methods for the research, it will take years. But with this technology it will only take a few days. It will incredibly accelerate our research capabilities.”
Dr Zigang Dong
Executive Director, Hormel Institute
University of Minnesota
Blue Gene supercomputers are currently in operation at 20 major research institutions, including Harvard and Princeton.
Hormel’s acquisition is part of major laboratory expansion project which includes new equipment and accommodations for 100 additional scientists. The facility’s grand opening is scheduled to take place October 3, 2008, to coincide with a worldwide cancer research conference.
Hormel is already conducting studies on breast cancer and skin cancer.
Source: Minnesota Public Radio
Related Links: marketwire.com; wcco.com; Top500.org
Technorati Tags: Austin, Minnesota; The Hormel Foundation
Print This
|
|
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URI
Leave a comment
Browse All Categories: Next article: Simple Steps Turn DNA Into Cancer-Grabbing Nanowires
Previous article: Europe OKs Oral Chemo for Advanced Colorectal Cancer
